{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:47:02Z","timestamp":1792021622798,"version":"4.4.0"},"reference-count":112,"publisher":"Bentham Science Publishers Ltd.","issue":"5","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872935"],"award-info":[{"award-number":["81872935"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDM"],"published-print":{"date-parts":[[2019,6,20]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Sodium Taurocholate Co-transporting Polypeptide (NTCP) and Bile Salt Export Pump (BSEP) play significant roles as membrane transporters because of their presence in the enterohepatic circulation of bile salts. They have emerged as promising drug targets in related liver disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We reviewed the literature published over the last 20 years with a focus on NTCP and BSEP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>This review summarizes the current perception about structure, function, genetic variation, and regulation of NTCP and BSEP, highlights the effects of their defects in some hepatic disorders, and discusses the application prospect of new transcriptional activators in liver diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>NTCP and BSEP are important proteins for transportation and homeostasis maintenance of bile acids. Further research is needed to develop new models for determining the structure-function relationship of bile acid transporters and screening for substrates and inhibitors, as well as to gain more information about the regulatory genetic mechanisms involved in the processes of liver injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1389200220666190426152830","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T15:59:38Z","timestamp":1556294378000},"page":"377-389","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The Role of the Sodium-taurocholate Co-transporting Polypeptide (NTCP) and Bile Salt Export Pump (BSEP) in Related Liver Disease"],"prefix":"10.2174","volume":"20","author":[{"given":"Xiaoyang","family":"Lu","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital, Zhejiang University, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Zhejiang University, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya","family":"Shan","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Zhejiang University, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Kong","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Zhejiang University, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Zhejiang University, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lou","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Zhejiang University, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Zeng","sequence":"additional","affiliation":[{"name":"Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","volume":"83","author":"Trauner M.","year":"2003","unstructured":"Trauner M, Boyer JL. Bile salt transporters: Molecular characterization, function, and regulation.","journal-title":"Physiol Rev"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/17425255.2011.557067","volume":"7","author":"Stieger B.","year":"2011","unstructured":"Stieger B, Geier A. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-642-14541-4_5","volume":"201","author":"Stieger B.","year":"2011","unstructured":"Stieger B. The role of the Sodium-taurocholate Cotransporting Polypeptide (NTCP) and of the Bile Salt Export Pump (BSEP) in physiology and pathophysiology of bile formation.","journal-title":"Handb Exp Pharmacol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.apsb.2015.01.001","volume":"5","author":"Ferrebee C.B.","year":"2015","unstructured":"Ferrebee CB, Dawson PA. Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids.","journal-title":"Acta Pharm Sin B"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/01.mpg.0000226384.71859.16","volume":"43","author":"Sokol R.J.","year":"2006","unstructured":"Sokol RJ, Devereaux M, Dahl R, Gumpricht E. \u201cLet there be bile\u201d-understanding hepatic injury in cholestasis.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/00498250802040584","volume":"38","author":"Kosters A.","year":"2008","unstructured":"Kosters A, Karpen SJ. Bile acid transporters in health and disease.","journal-title":"Xenobiotica"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.ddtec.2014.03.006","volume":"12","author":"Kubitz R.","year":"2014","unstructured":"Kubitz R, Droge C, Kluge S, Stindt J, Haussinger D. Genetic variations of bile salt transporters.","journal-title":"Drug Discov Today Technol"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11095-007-9289-1","volume":"24","author":"Alrefai W.A.","year":"2007","unstructured":"Alrefai WA, Gill RK. Bile acid transporters: Structure, function, regulation and pathophysiological implications.","journal-title":"Pharm Res"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mam.2013.12.001","volume":"37","author":"Baghdasaryan A.","year":"2014","unstructured":"Baghdasaryan A, Chiba P, Trauner M. Clinical application of transcriptional activators of bile salt transporters.","journal-title":"Mol Aspects Med"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.mam.2012.07.004","volume":"34","author":"Claro D.S.T.","year":"2013","unstructured":"Claro DST, Polli JE, Swaan PW. The solute carrier family 10 (SLC10): Beyond bile acid transport.","journal-title":"Mol Aspects Med"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00424-013-1367-0","volume":"466","author":"Anwer M.S.","year":"2014","unstructured":"Anwer MS, Stieger B. Sodium-dependent bile salt transporters of the SLC10A transporter family: More than solute transporters.","journal-title":"Pflugers Arch"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1053\/gast.1997.v113.pm9322525","volume":"113","author":"Kullak-Ublick G.A.","year":"1997","unstructured":"Kullak-Ublick GA, Glasa J, Boker C, Oswald M, Grutzner U, Hagenbuch B, Stieger B, Meier PJ, Beuers U, Kramer W, Wess G, Paumgartner G. Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas.","journal-title":"Gastroenterology"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1053\/gast.2002.33617","volume":"122","author":"Kim J.Y.","year":"2002","unstructured":"Kim JY, Kim KH, Lee JA, Namkung W, Sun AQ, Ananthanarayanan M, Suchy FJ, Shin DM, Muallem S, Lee MG. Transporter-mediated bile acid uptake causes Ca2+-dependent cell death in rat pancreatic acinar cells.","journal-title":"Gastroenterology"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(03)00096-5","volume":"38","author":"Zollner G.","year":"2003","unstructured":"Zollner G, Fickert P, Silbert D, Fuchsbichler A, Marschall HU, Zatloukal K, Denk H, Trauner M. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.","journal-title":"J Hepatol"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"56041","DOI":"10.18632\/oncotarget.10241","volume":"8","author":"Kang J.","year":"2017","unstructured":"Kang J, Wang J, Cheng J, Cao Z, Chen R, Li H, Liu S, Chen X, Sui J, Lu F. Down-regulation of NTCP expression by cyclin D1 in hepatitis B virus-related hepatocellular carcinoma has clinical significance.","journal-title":"Oncotarget"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.celrep.2016.09.084","volume":"17","author":"Verrier E.R.","year":"2016","unstructured":"Verrier ER, Colpitts CC, Bach C, Heydmann L, Zona L, Xiao F, Thumann C, Crouchet E, Gaudin R, Sureau C, Cosset FL, McKeating JA, Pessaux P, Hoshida Y, Schuster C, Zeisel MB, Baumert TF. Solute carrier NTCP regulates innate antiviral immune responses targeting hepatitis C virus infection of hepatocytes.","journal-title":"Cell Reports"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1074\/jbc.M305782200","volume":"279","author":"Ho R.H.","year":"2004","unstructured":"Ho RH, Leake BF, Roberts RL, Lee W, Kim RB. Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition.","journal-title":"J Biol Chem"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.meegid.2014.07.001","volume":"27","author":"Su Z.","year":"2014","unstructured":"Su Z, Li Y, Liao Y, Cai B, Chen J, Zhang J, Li L, Ying B, Tao C, Wang L. Association of the gene polymorphisms in sodium taurocholate cotransporting polypeptide with the outcomes of hepatitis B infection in Chinese Han population.","journal-title":"Infect Genet Evol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.27608","volume":"61","author":"Peng L.","year":"2015","unstructured":"Peng L, Zhao Q, Li Q, Li M, Li C, Xu T, Jing X, Zhu X, Wang Y, Li F, Liu R, Zhong C, Pan Q, Zeng B, Liao Q, Hu B, Hu ZX, Huang YS, Sham P, Liu J, Xu S, Wang J, Gao ZL, Wang Y. The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B.","journal-title":"Hepatology"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.27240","volume":"61","author":"Vaz F.M.","year":"2015","unstructured":"Vaz FM, Paulusma CC, Huidekoper H, De Ru M, Lim C, Koster J, Ho-Mok K, Bootsma AH, Groen AK, Schaap FG, Oude ERP, Waterham HR, Wanders RJ. Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: Conjugated hypercholanemia without a clear clinical phenotype.","journal-title":"Hepatology"},{"key":"ref=21","first-page":"501","volume":"6","author":"Wei P.","year":"2011","unstructured":"Wei P. Genetic polymorphisms in Na+-taurocholate Co-transporting Polypeptide (NTCP) and ileal Apical Sodium-dependent Bile Acid Transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations.","journal-title":"Xenobiotica"},{"key":"ref=22","first-page":"134","volume":"7","author":"Yu Y.","year":"2018","unstructured":"Yu Y, Li S, Liang W. Bona fide receptor for hepatitis B and D viral infections: Mechanism, research models and molecular drug targets.","journal-title":"Microbes Infect"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1053\/j.gastro.2006.02.034","volume":"130","author":"Ho R.H.","year":"2006","unstructured":"Ho RH, Tirona RG, Leake BF, Glaeser H, Lee W, Lemke CJ, Wang Y, Kim RB. Drug and bile acid transporters in rosuvastatin hepatic uptake: Function, expression, and pharmacogenetics.","journal-title":"Gastroenterology"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","volume":"1","author":"Yan H.","year":"2012","unstructured":"Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.","journal-title":"eLife"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","volume":"146","author":"Ni Y.","year":"2014","unstructured":"Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Falth M, Stindt J, Koniger C, Nassal M, Kubitz R, Sultmann H, Urban S. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.","journal-title":"Gastroenterology"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1128\/JVI.03478-13","volume":"88","author":"Yan H.","year":"2014","unstructured":"Yan H, Peng B, Liu Y, Xu G, He W, Ren B, Jing Z, Sui J, Li W. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.","journal-title":"J Virol"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/jhep.2003.50100","volume":"37","author":"Jung D.","year":"2003","unstructured":"Jung D, Kullak-Ublick GA. Hepatocyte nuclear factor 1 alpha: A key mediator of the effect of bile acids on gene expression.","journal-title":"Hepatology"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00432-013-1554-6","volume":"140","author":"Jang E.S.","year":"2014","unstructured":"Jang ES, Yoon JH, Lee SH, Lee SM, Lee JH, Yu SJ, Kim YJ, Lee HS, Kim CY. Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"G782","DOI":"10.1152\/ajpgi.00379.2003","volume":"287","author":"Simon F.R.","year":"2004","unstructured":"Simon FR, Fortune J, Iwahashi M, Qadri I, Sutherland E. Multihormonal regulation of hepatic sinusoidal Ntcp gene expression.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"G550","DOI":"10.1152\/ajpgi.00364.2005","volume":"290","author":"Mita S.","year":"2006","unstructured":"Mita S, Suzuki H, Akita H, Hayashi H, Onuki R, Hofmann AF, Sugiyama Y. Vectorial transport of unconjugated and conjugated bile salts by monolayers of LLC-PK1 cells doubly transfected with human NTCP and BSEP or with rat NTCP and BSEP.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1124\/mol.61.4.853","volume":"61","author":"Briz O.","year":"2002","unstructured":"Briz O, Serrano MA, Rebollo N, Hagenbuch B, Meier PJ, Koepsell H, Marin JJ. Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells.","journal-title":"Mol Pharmacol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s00204-014-1379-3","volume":"89","author":"Grosser G.","year":"2015","unstructured":"Grosser G, Doring B, Ugele B, Geyer J, Kulling SE, Soukup ST. Transport of the soy isoflavone daidzein and its conjugative metabolites by the carriers SOAT, NTCP, OAT4, and OATP2B1.","journal-title":"Arch Toxicol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cpr.12117","volume":"47","author":"Fu L.L.","year":"2014","unstructured":"Fu LL, Liu J, Chen Y, Wang FT, Wen X, Liu HQ, Wang MY, Ouyang L, Huang J, Bao JK, Wei YQ. analysis and experimental validation of azelastine hydrochloride (N4) targeting sodium taurocholate co-transporting polypeptide (NTCP) in HBV therapy.","journal-title":"Cell Prolif"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/dmd.105.008748","volume":"34","author":"Mita S.","year":"2006","unstructured":"Mita S, Suzuki H, Akita H, Hayashi H, Onuki R, Hofmann AF, Sugiyama Y. Inhibition of bile acid transport across Na+\/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.","journal-title":"Drug Metab Dispos"},{"key":"ref=35","first-page":"1204","volume":"291","author":"Kim R.B.","year":"1999","unstructured":"Kim RB, Leake B, Cvetkovic M, Roden MM, Nadeau J, Walubo A, Wilkinson GR. Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1124\/jpet.106.102657","volume":"318","author":"McRae M.P.","year":"2006","unstructured":"McRae MP, Lowe CM, Tian X, Bourdet DL, Ho RH, Leake BF, Kim RB, Brouwer KL, Kashuba AD. Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/jpet.106.119073","volume":"321","author":"Leslie E.M.","year":"2007","unstructured":"Leslie EM, Watkins PB, Kim RB, Brouwer KL. Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP\/SLC10A1) by bosentan: A mechanism for species differences in hepatotoxicity.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"e87548","DOI":"10.1371\/journal.pone.0087548","volume":"9","author":"Lepist E.I.","year":"2014","unstructured":"Lepist EI, Gillies H, Smith W, Hao J, Hubert C, St CRL, Brouwer KR, Ray AS. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.","journal-title":"PLoS One"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1172\/JCI117091","volume":"93","author":"Hagenbuch B.","year":"1994","unstructured":"Hagenbuch B, Meier PJ. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+\/bile acid cotransporter.","journal-title":"J Clin Invest"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/toxsci\/kfs188","volume":"129","author":"Greupink R.","year":"2012","unstructured":"Greupink R, Nabuurs SB, Zarzycka B, Verweij V, Monshouwer M, Huisman MT, Russel FG. In silico identification of potential cholestasis-inducing agents via modeling of Na(+)-dependent taurocholate cotransporting polypeptide substrate specificity.","journal-title":"Toxicol Sci"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1038\/mtna.2014.68","volume":"3","author":"Seeger C.","year":"2014","unstructured":"Seeger C, Sohn JA. Targeting hepatitis b virus with CRISPR\/Cas9.","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","volume":"443","author":"Iwamoto M.","year":"2014","unstructured":"Iwamoto M, Watashi K, Tsukuda S, Aly HH, Fukasawa M, Fujimoto A, Suzuki R, Aizaki H, Ito T, Koiwai O, Kusuhara H, Wakita T. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijpharm.2014.11.022","volume":"478","author":"Dong Z.","year":"2015","unstructured":"Dong Z, Ekins S, Polli JE. A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide.","journal-title":"Int J Pharm"},{"key":"ref=44","first-page":"549","volume":"14","author":"Shen Z.W.","year":"2016","unstructured":"Shen ZW, Luo MY, Hu HH, Zhou H, Jiang HD, Yu LS, Zeng S. Screening and verifying potential NTCP inhibitors from herbal medicinal ingredients using the LLC-PK1 cell model stably expressing human NTCP.","journal-title":"Chin J Nat Med"},{"key":"ref=45","first-page":"G157","volume":"274","author":"Craddock A.L.","year":"1998","unstructured":"Craddock AL, Love MW, Daniel RW, Kirby LC, Walters HC, Wong MH, Dawson PA. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter.","journal-title":"Am J Physiol"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/mp050063u","volume":"3","author":"Maeda K.","year":"2006","unstructured":"Maeda K, Kambara M, Tian Y, Hofmann AF, Sugiyama Y. Uptake of ursodeoxycholate and its conjugates by human hepatocytes: Role of Na(+)-taurocholate Cotransporting Polypeptide (NTCP), Organic Anion Transporting Polypeptide (OATP) 1B1 (OATP-C), and oatp1B3 (OATP8).","journal-title":"Mol Pharm"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/bdd.629","volume":"29","author":"Yabuuchi H.","year":"2008","unstructured":"Yabuuchi H, Tanaka K, Maeda M, Takemura M, Oka M, Ohashi R, Tamai I. Cloning of the dog bile salt export pump (BSEP; ABCB11) and functional comparison with the human and rat proteins.","journal-title":"Biopharm Drug Dispos"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/hep.510260641","volume":"26","author":"Meier P.J.","year":"1997","unstructured":"Meier PJ, Eckhardt U, Schroeder A, Hagenbuch B, Stieger B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver.","journal-title":"Hepatology"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ejps.2011.09.009","volume":"44","author":"Greupink R.","year":"2011","unstructured":"Greupink R, Dillen L, Monshouwer M, Huisman MT, Russel FG. Interaction of fluvastatin with the liver-specific Na+ -dependent Taurocholate Cotransporting Polypeptide (NTCP).","journal-title":"Eur J Pharm Sci"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/00498254.2010.523736","volume":"41","author":"Choi M.K.","year":"2011","unstructured":"Choi MK, Shin HJ, Choi YL, Deng JW, Shin JG, Song IS. Differential effect of genetic variants of Na(+)-taurocholate Co-Transporting Polypeptide (NTCP) and Organic anion-transporting Polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors.","journal-title":"Xenobiotica"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mce.2009.08.003","volume":"315","author":"Visser W.E.","year":"2010","unstructured":"Visser WE, Wong WS, van Mullem AA, Friesema EC, Geyer J, Visser TJ. Study of the transport of thyroid hormone by transporters of the SLC10 family.","journal-title":"Mol Cell Endocrinol"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/mp400699p","volume":"11","author":"Gozalpour E.","year":"2014","unstructured":"Gozalpour E, Greupink R, Wortelboer HM, Bilos A, Schreurs M, Russel FG, Koenderink JB. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.","journal-title":"Mol Pharm"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1517\/14728222.2016.1102889","volume":"20","author":"Telbisz A.","year":"2016","unstructured":"Telbisz A, Homolya L. Recent advances in the exploration of the bile salt export pump (BSEP\/ABCB11) function.","journal-title":"Expert Opin Ther Targets"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.tiv.2015.03.019","volume":"29","author":"Le V.M.","year":"2015","unstructured":"Le VM, Jouan E, Noel G, Stieger B, Fardel O. Polarized location of SLC and ABC drug transporters in monolayer-cultured human hepatocytes.","journal-title":"Toxicol In Vitro"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2003.11.003","volume":"126","author":"Kubitz R.","year":"2004","unstructured":"Kubitz R, Sutfels G, Kuhlkamp T, Kolling R, Haussinger D. Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase.","journal-title":"Gastroenterology"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/humu.22138","volume":"33","author":"Gyimesi G.","year":"2012","unstructured":"Gyimesi G, Borsodi D, Saranko H, Tordai H, Sarkadi B, Hegedus T. ABCMdb: A database for the comparative analysis of protein mutations in ABC transporters, and a potential framework for a general application.","journal-title":"Hum Mutat"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.ajpath.2017.08.011","volume":"187","author":"Liu L.","year":"2017","unstructured":"Liu L, Zhang L, Zhang L, Yang F, Zhu X, Lu Z, Yang Y, Lu H, Feng L, Wang Z, Chen H, Yan S, Wang L, Ju Z, Jin H, Zhu X. Hepatic Tmem30a deficiency causes intrahepatic cholestasis by impairing expression and localization of bile salt transporters.","journal-title":"Am J Pathol"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"C1709","DOI":"10.1152\/ajpcell.00327.2007","volume":"293","author":"Lam P.","year":"2007","unstructured":"Lam P, Pearson CL, Soroka CJ, Xu S, Mennone A, Boyer JL. Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep\/Abcb11) correlate with severity of cholestatic diseases.","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.3748\/wjg.v23.i29.5295","volume":"23","author":"Ellinger P.","year":"2017","unstructured":"Ellinger P, Stindt J, Droge C, Sattler K, Stross C, Kluge S, Herebian D. SHJ, S.; Burdelski, M.; Schulz-Jurgensen, S.; Ballauff, A.; Schulte, A.E.J.; Mayatepek, E.; Haussinger, D.; Kubitz, R.; Schmitt, L. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.","journal-title":"World J Gastroenterol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"24827","DOI":"10.1038\/srep24827","volume":"6","author":"Droge C.","year":"2016","unstructured":"Droge C, Schaal H, Engelmann G, Wenning D, Haussinger D, Kubitz R. Exon-skipping and mRNA decay in human liver tissue: Molecular consequences of pathogenic bile salt export pump mutations.","journal-title":"Sci Rep"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hep.21987","volume":"47","author":"Glantz A.","year":"2008","unstructured":"Glantz A, Reilly SJ, Benthin L, Lammert F, Mattsson LA, Marschall HU. Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine.","journal-title":"Hepatology"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.22683","volume":"49","author":"Byrne J.A.","year":"2009","unstructured":"Byrne JA, Strautnieks SS, Ihrke G, Pagani F, Knisely AS, Linton KJ, Mieli-Vergani G, Thompson RJ. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing.","journal-title":"Hepatology"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/cpt.1222","volume":"104","author":"Kenna J.G.","year":"2018","unstructured":"Kenna JG, Taskar KS, Battista C, Bourdet DL. KLR, B.; Brouwer, K.R.; Dai, D.; Funk, C.; Hafey, M.J.; Lai, Y.; Maher, J.; Pak, Y.A.; Pedersen, J.M.; Polli, J.W.; Rodrigues, A.D.; Watkins, P.B.; Yang, K.; Yucha, R.W. Can bile salt export pump inhibition testing in drug discovery and development reduce liver injury risk? An international transporter consortium perspective.","journal-title":"Clin Pharmacol Ther"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1124\/jpet.117.242370","volume":"362","author":"Cheng Y.","year":"2017","unstructured":"Cheng Y, Chen S, Freeden C, Chen W, Zhang Y, Abraham P, Nelson DM, Humphreys WG, Gan J, Lai Y. Bile salt homeostasis in normal and BSEP gene knockout rats with single and repeated doses of troglitazone.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clinre.2012.06.006","volume":"36","author":"Kubitz R.","year":"2012","unstructured":"Kubitz R, Droge C, Stindt J, Weissenberger K, Haussinger D. The Bile Salt Export Pump (BSEP) in health and disease.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.3748\/wjg.v22.i20.4901","volume":"22","author":"Park J.S.","year":"2016","unstructured":"Park JS, Ko JS, Seo JK, Moon JS, Park SS. Clinical and ABCB11 profiles in Korean infants with progressive familial intrahepatic cholestasis.","journal-title":"World J Gastroenterol"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.28779","volume":"65","author":"Gonzales E.","year":"2017","unstructured":"Gonzales E, Taylor SA, Davit-Spraul A, Thebaut A, Thomassin N, Guettier C, Whitington PF, Jacquemin E. MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.","journal-title":"Hepatology"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/j.gastro.2008.01.038","volume":"134","author":"Strautnieks S.S.","year":"2008","unstructured":"Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerova D, Rayner A, Dutton L, Meier Y, Antoniou A, Stieger B, Arnell H, Ozcay F, Al-Hussaini HF, Bassas AF, Verkade HJ, Fischler B, Nemeth A, Kotalova R, Shneider BL, Cielecka-Kuszyk J, McClean P, Whitington PF, Sokal E, Jirsa M, Wali SH, Jankowska I, Pawlowska J, Mieli-Vergani G, Knisely AS, Bull LN, Thompson RJ. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.","journal-title":"Gastroenterology"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/hep.27171","volume":"60","author":"Song X.","year":"2014","unstructured":"Song X, Vasilenko A, Chen Y, Valanejad L, Verma R, Yan B, Deng R. Transcriptional dynamics of bile salt export pump during pregnancy: Mechanisms and implications in intrahepatic cholestasis of pregnancy.","journal-title":"Hepatology"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1440-1746.2005.03725.x","volume":"20","author":"Jorquera F.","year":"2005","unstructured":"Jorquera F, Monte MJ, Guerra J, Sanchez-Campos S, Merayo JA, Olcoz JL, Gonzalez-Gallego J, Marin JJ. Usefulness of combined measurement of serum bile acids and ferritin as additional prognostic markers to predict failure to reach sustained response to antiviral treatment in chronic hepatitis C.","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2893.2010.01363.x","volume":"18","author":"Iwata R.","year":"2011","unstructured":"Iwata R, Stieger B, Mertens JC, Muller T, Baur K, Frei P, Braun J, Vergopoulos A, Martin IV, Schmitt J, Goetze O, Bibert S, Bochud PY, Mullhaupt B, Berg T, Geier A. The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C.","journal-title":"J Viral Hepat"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-230X-12-63","volume":"12","author":"Mullenbach R.","year":"2012","unstructured":"Mullenbach R, Weber SN, Krawczyk M, Zimmer V, Sarrazin C, Lammert F, Grunhage F. A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population.","journal-title":"BMC Gastroenterol"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12876-017-0594-9","volume":"17","author":"Lei J.H.","year":"2017","unstructured":"Lei JH, Yang X, Xiao XQ, Chen Z, Peng F. A preliminary investigation on single nucleotide polymorphism rs2287622 of bile salt export pump gene in patients with chronic hepatitis C virus infection in Hunan, China.","journal-title":"BMC Gastroenterol"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1124\/dmd.117.077289","volume":"46","author":"Billington S.","year":"2018","unstructured":"Billington S, Ray AS, Salphati L, Xiao G, Chu X, Humphreys WG, Liao M, Lee CA, Mathias A. CECA, H.; Rowbottom, C.; Evers, R.; Lai, Y.; Kelly, E.J.; Prasad, B.; Unadkat, J.D. Transporter expression in noncancerous and cancerous liver tissue from donors with hepatocellular carcinoma and chronic hepatitis c infection quantified by LC-MS\/MS proteomics.","journal-title":"Drug Metab Dispos"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/FPC.0b013e3283349eb0","volume":"20","author":"Ho R.H.","year":"2010","unstructured":"Ho RH, Leake BF, Kilkenny DM, Meyer ZSHE, Glaeser H, Kroetz DL, Kim RB. Polymorphic variants in the human Bile Salt Export Pump (BSEP; ABCB11): functional characterization and interindividual variability.","journal-title":"Pharmacogenet Genomics"},{"key":"ref=76","first-page":"138","volume":"11","author":"Simmermacher J.","year":"2017","unstructured":"Simmermacher J, Sinz M. Evaluation of farnesoid X receptor target gene induction in human hepatocytes: Amino acid conjugation.","journal-title":"Drug Metab Lett"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1677\/joe.1.06105","volume":"188","author":"Honjo Y.","year":"2006","unstructured":"Honjo Y, Sasaki S, Kobayashi Y, Misawa H, Nakamura H. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.","journal-title":"J Endocrinol"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1248\/bpb.b17-00972","volume":"41","author":"Guo S.","year":"2018","unstructured":"Guo S, Zhang S, Liu L, Yang P, Dang X, Wei H, Hu N, Shi L, Zhang Y. Praeparatum involved in the regulation of bile acids metabolism in hepatic injury.","journal-title":"Biol Pharm Bull"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"e91921","DOI":"10.1371\/journal.pone.0091921","volume":"9","author":"Homolya L.","year":"2014","unstructured":"Homolya L, Fu D, Sengupta P, Jarnik M, Gillet JP, Vitale-Cross L, Gutkind JS, Lippincott-Schwartz J, Arias IM. LKB1\/AMPK and PKA control ABCB11 trafficking and polarization in hepatocytes.","journal-title":"PLoS One"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"26638","DOI":"10.1074\/jbc.273.41.26638","volume":"273","author":"Misra S.","year":"1998","unstructured":"Misra S, Ujhazy P, Gatmaitan Z, Varticovski L, Arias IM. The role of phosphoinositide 3-kinase in taurocholate-induced trafficking of ATP-dependent canalicular transporters in rat liver.","journal-title":"J Biol Chem"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mam.2013.05.001","volume":"37","author":"Soroka C.J.","year":"2014","unstructured":"Soroka CJ, Boyer JL. Biosynthesis and trafficking of the bile salt export pump, BSEP: Therapeutic implications of BSEP mutations.","journal-title":"Mol Aspects Med"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/iub.1689","volume":"69","author":"Marrone J.","year":"2017","unstructured":"Marrone J, Danielli M, Gaspari CI, Marinelli RA. Adenovirus-mediated human aquaporin-1 expression in hepatocytes improves lipopolysaccharide-induced cholestasis.","journal-title":"IUBMB Life"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0148607111424412","volume":"36","author":"Li J.","year":"2012","unstructured":"Li J, Gong YM, Wu J, Wu WJ, Cai W. Anti-tumor necrosis factor-alpha monoclonal antibody alleviates parenteral nutrition-associated liver disease in mice.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"31185","DOI":"10.1074\/jbc.M110.107805","volume":"285","author":"Diao L.","year":"2010","unstructured":"Diao L, Li N, Brayman TG, Hotz KJ, Lai Y. Regulation of MRP2\/ABCC2 and BSEP\/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-alpha, IL-6, and IL-1beta.","journal-title":"J Biol Chem"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/jpet.109.151233","volume":"330","author":"Kaimal R.","year":"2009","unstructured":"Kaimal R, Song X, Yan B, King R, Deng R. Differential modulation of farnesoid X receptor signaling pathway by the thiazolidinediones.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/jpet.105.084830","volume":"314","author":"Hirano M.","year":"2005","unstructured":"Hirano M, Maeda K, Hayashi H, Kusuhara H, Sugiyama Y. Bile Salt Export Pump (BSEP\/ABCB11) can transport a nonbile acid substrate, pravastatin.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/18723128112066660018","volume":"7","author":"Daniels J.S.","year":"2013","unstructured":"Daniels JS, Lai Y, South S, Chiang PC, Walker D, Feng B, Mireles R, Whiteley LO, McKenzie JW, Stevens J, Mourey R, Anderson D, Davis IJW. Inhibition of hepatobiliary transporters by a novel kinase inhibitor contributes to hepatotoxicity in beagle dogs.","journal-title":"Drug Metab Lett"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1172\/JCI116120","volume":"90","author":"Wolters H.","year":"1992","unstructured":"Wolters H, Kuipers F, Slooff MJ, Vonk RJ. Adenosine triphosphate-dependent taurocholate transport in human liver plasma membranes.","journal-title":"J Clin Invest"},{"key":"ref=89","first-page":"G1153","volume":"276","author":"Niinuma K.","year":"1999","unstructured":"Niinuma K, Kato Y, Suzuki H, Tyson CA, Weizer V, Dabbs JE, Froehlich R, Green CE, Sugiyama Y. Primary active transport of organic anions on bile canalicular membrane in humans.","journal-title":"Am J Physiol"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1053\/gast.2002.36587","volume":"123","author":"Noe J.","year":"2002","unstructured":"Noe J, Stieger B, Meier PJ. Functional expression of the canalicular bile salt export pump of human liver.","journal-title":"Gastroenterology"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbalip.2005.10.006","volume":"1738","author":"Hayashi H.","year":"2005","unstructured":"Hayashi H, Takada T, Suzuki H, Onuki R, Hofmann AF, Sugiyama Y. Transport by vesicles of glycine- and taurine-conjugated bile salts and taurolithocholate 3-sulfate: a comparison of human BSEP with rat Bsep.","journal-title":"Biochim Biophys Acta"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1124\/dmd.108.024778","volume":"37","author":"Kis E.","year":"2009","unstructured":"Kis E, Ioja E, Nagy T, Szente L, Heredi-Szabo K, Krajcsi P. Effect of membrane cholesterol on BSEP\/Bsep activity: Species specificity studies for substrates and inhibitors.","journal-title":"Drug Metab Dispos"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2116\/analsci.25.1155","volume":"25","author":"Yamaguchi K.","year":"2009","unstructured":"Yamaguchi K, Murai T, Yabuuchi H, Kurosawa T. Measurement of the transport activities of bile salt export pump using LC-MS.","journal-title":"Anal Sci"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2133\/dmpk.18.16","volume":"18","author":"Horikawa M.","year":"2003","unstructured":"Horikawa M, Kato Y, Tyson CA, Sugiyama Y. Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans.","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/toxsci\/kfp033","volume":"108","author":"Feng B.","year":"2009","unstructured":"Feng B, Xu JJ, Bi YA, Mireles R, Davidson R, Duignan DB, Campbell S, Kostrubsky VE, Dunn MC, Smith AR, Wang HF. Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.","journal-title":"Toxicol Sci"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/toxsci\/kfg217","volume":"76","author":"Kostrubsky V.E.","year":"2003","unstructured":"Kostrubsky VE, Strom SC, Hanson J, Urda E, Rose K, Burliegh J, Zocharski P, Cai H, Sinclair JF, Sahi J. Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats.","journal-title":"Toxicol Sci"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/mp060004w","volume":"3","author":"Hirano H.","year":"2006","unstructured":"Hirano H, Kurata A, Onishi Y, Sakurai A, Saito H, Nakagawa H, Nagakura M, Tarui S, Kanamori Y, Kitajima M, Ishikawa T. High-speed screening and QSAR analysis of human ATP-binding cassette transporter ABCB11 (bile salt export pump) to predict drug-induced intrahepatic cholestasis.","journal-title":"Mol Pharm"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.fpc.0000230418.28091.76","volume":"17","author":"Lang C.","year":"2007","unstructured":"Lang C, Meier Y, Stieger B, Beuers U, Lang T, Kerb R, Kullak-Ublick GA, Meier PJ, Pauli-Magnus C. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury.","journal-title":"Pharmacogenet Genomics"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/17425255.4.4.363","volume":"4","author":"Funk C.","year":"2008","unstructured":"Funk C. The role of hepatic transporters in drug elimination.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/toxsci\/kfj095","volume":"90","author":"Kostrubsky S.E.","year":"2006","unstructured":"Kostrubsky SE, Strom SC, Kalgutkar AS, Kulkarni S, Atherton J, Mireles R, Feng B, Kubik R, Hanson J, Urda E, Mutlib AE. Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone.","journal-title":"Toxicol Sci"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/bdd.527","volume":"28","author":"Mano Y.","year":"2007","unstructured":"Mano Y, Usui T, Kamimura H. Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2.","journal-title":"Biopharm Drug Dispos"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","volume":"50","author":"Dawson P.A.","year":"2009","unstructured":"Dawson PA, Lan T, Rao A. Bile acid transporters.","journal-title":"J Lipid Res"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/hep.27206","volume":"60","author":"Aleo M.D.","year":"2014","unstructured":"Aleo MD, Luo Y, Swiss R, Bonin PD, Potter DM, Will Y. Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.","journal-title":"Hepatology"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cbi.2016.03.019","volume":"255","author":"Zhang J.","year":"2016","unstructured":"Zhang J, He K, Cai L, Chen YC, Yang Y, Shi Q, Woolf TF, Ge W, Guo L, Borlak J, Tong W. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.","journal-title":"Chem Biol Interact"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/toxsci\/kft176","volume":"136","author":"Morgan R.E.","year":"2013","unstructured":"Morgan RE, Van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.","journal-title":"Toxicol Sci"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/toxsci\/kft197","volume":"136","author":"Pedersen J.M.","year":"2013","unstructured":"Pedersen JM, Matsson P, Bergstrom CA, Hoogstraate J, Noren A, LeCluyse EL, Artursson P. Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP\/ABCB11).","journal-title":"Toxicol Sci"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/clpt.2014.158","volume":"96","author":"Yang K.","year":"2014","unstructured":"Yang K, Woodhead JL, Watkins PB, Howell BA, Brouwer KL. Systems pharmacology modeling predicts delayed presentation and species differences in bile acid-mediated troglitazone hepatotoxicity.","journal-title":"Clin Pharmacol Ther"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0016-5085(03)00401-3","volume":"124","author":"Newsome P.N.","year":"2003","unstructured":"Newsome PN, Johannessen I, Boyle S, Dalakas E, McAulay KA, Samuel K, Rae F, Forrester L, Turner ML, Hayes PC, Harrison DJ, Bickmore WA, Plevris JN. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion.","journal-title":"Gastroenterology"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"e15689","DOI":"10.1371\/journal.pone.0015689","volume":"5","author":"Peters R.","year":"2010","unstructured":"Peters R, Wolf MJ, Van Den Broek M, Nuvolone M, Dannenmann S, Stieger B, Rapold R, Konrad D, Rubin A, Bertino JR, Aguzzi A, Heikenwalder M, Knuth AK. Efficient generation of multipotent mesenchymal stem cells from umbilical cord blood in stroma-free liquid culture.","journal-title":"PLoS One"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s12015-010-9189-3","volume":"6","author":"Ghodsizadeh A.","year":"2010","unstructured":"Ghodsizadeh A, Taei A, Totonchi M, Seifinejad A, Gourabi H, Pournasr B, Aghdami N, Malekzadeh R, Almadani N, Salekdeh GH, Baharvand H. Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells.","journal-title":"Stem Cell Rev"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1172\/JCI43122","volume":"120","author":"Rashid S.T.","year":"2010","unstructured":"Rashid ST, Corbineau S, Hannan N, Marciniak SJ, Miranda E, Alexander G, Huang-Doran I, Griffin J, Ahrlund-Richter L, Skepper J, Semple R, Weber A, Lomas DA, Vallier L. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.","journal-title":"J Clin Invest"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jhep.2010.05.009","volume":"4","author":"Asgari S.","year":"2010","unstructured":"Asgari S, Pournasr B, Salekdeh GH, Ghodsizadeh A, Ott M, Baharvand H. Induced pluripotent stem cells: A new era for hepatology.","journal-title":"J Hepatol"}],"container-title":["Current Drug Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/171868","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:01:49Z","timestamp":1607385709000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/171868\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":112,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,6,20]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389200220666190426152830","relation":{},"ISSN":["1389-2002"],"issn-type":[{"value":"1389-2002","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}